EPCAM and cancer: Therefore we used Caco-2 (CD133+, EpCAM+) and HT-29 (CD133−, EpCAM+) targets and performed the assay with freshly isolated NK cells of two donors for each cancer cell line (Figure 3A, 3B) and (3C, 3D) respectively.